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A B S T R A C T
Objectives: The purpose of this study was to estimate the quality-adjusted life expectancy
(QALE) and the expected lifetime utility loss of patients with prolonged mechanical venti-
lation (PMV).
Methods: PMV was defined as more than 21 days of mechanical ventilation. A total of 633
patients fulfilled this definition and were followed for 9 years (1998–2007) to obtain their
survival status. Quality of life of 142 patients was measured with the EuroQol five-dimen-
sional (EQ-5D) questionnaire during the period 2008 to 2009. The survival probabilities for
each time point were adjustedwith a utilitymeasurement of quality of life and then extrap-
olated to 300months to obtain the QALE.We compared the age-, gender-matched reference
populations to calculate the expected lifetime utility loss.
Results: The average age of subjects was 76 years old. The life expectancy and loss of life
expectancywere 1.95 years and 8.48 years, respectively. TheQALE of 55 patientswith partial
cognitive ability and the ability to respond was 0.58 quality-adjusted life years (QALY),
whereas the QALEs of 87 patients with poor consciousness were 0.28 and 0.29 QALY for the
EQ-5D measured by family caregivers and nurses, respectively. The loss of QALE for PMV
patients was 9.87 to 10.17 QALY, corresponding to a health gap of 94% to 97%.
Conclusions: Theses results of poor prognosis would provide stakeholders evidence for
communication to facilitate clinical decisions. The estimationmay be used in future studies
to facilitate the cost-effectiveness and reduction of the health gap.
Copyright © 2011, International Society for Pharmacoeconomics and Outcomes Research(ISPOR). Published by Elsevier Inc.
Funding: Supported, in part, by the National Science Council (Grant 98-2341-B-002-129), National Health Research Institutes (Grant
97A1-HDPP01-014 and 98A1-PHAPHD-014), and Chia-Yi Christian Hospital (Grant R97-9 and R98-3) in Taiwan. The authors declare that
there is no potential conflict of interest.
* Address correspondence to: Jung-Der Wang, Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, Na-
tional Taiwan University, Rm. 719, No 17, Xuhzou Road, Taipei, Taiwan, 10055.
E-mail: jdwang@ntu.edu.tw.
1098-3015/$36.00 – see front matter Copyright © 2011, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Published by Elsevier Inc.
doi:10.1016/j.jval.2010.09.006
348 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 3 4 7 – 3 5 3Introduction
The number of patients requiring prolonged mechanical ven-
tilation (PMV) is rapidly increasing, because the improved
quality of care in ICUs (intensive care units) has resulted in the
long-term survival of many patients [1–3]. However, these pa-
tients often continually require respiratory care after transfer
to a rehabilitation facility, skilled nursing facility, or home
care, and this creates a tremendous financial burden for the
insurance system and/or their families [2,3]. The financial im-
pact is particularly heavy for countries with a national health
insurance systemwith universal coverage of their citizens and
is aggravated by the innovation of new technologies and an
aging population [4]. Most of these countries have adopted
economic analyses to improve overall cost-effectiveness and
contain costs [5–7]. Evaluation of the cost per quality-adjusted
life year (QALY) gained from different healthcare services will
ensure the most cost-effective policy decision for health care.
The National Health Insurance (NHI) of Taiwan adopts a
system of comprehensive coverage for various health-care
services, includingmaintenance hemodialysis and chronic re-
spiratory care. It was first established in 1995 and has been
extended to cover more than 99% of the citizens of Taiwan
[8,9]. The NHI established a Pilot Program of Ventilator Depen-
dent Managed Care in 2002 to provide subsequent and long-
term care for patients using PMV who are overcrowding the
ICU. The program intended to cover medical services in the
acute stage in the ICU, during weaning trials in the respiratory
care center, dispatch to the respiratory care ward if weaning
trials failed, and respiratory therapy in home care. Because
the expense of chronic care for patients under PMV at home is
generally too profound for most families, many try to keep
their loved ones at the respiratory care ward for as long as
possible. Thus, the reimbursement has resulted in a large fi-
nancial burden for the NHI. During 2005, the total number of
PMV patients who required respiratory care in the NHI of Tai-
wan reached 30,000 and accounted for 7.5% of the total NHI
health-care expenditures, and this has nowbecome one of the
major threats to the sustainability of the NHI [10,11].
This study has considered both long-term survival and qual-
ity of life (QOL) together for PMV patients. Such a lack of prog-
nostic data plus the families’ unreasonably optimistic expecta-
tions often complicates the family-physician interaction [12],
and makes it difficult to communicate among patients, their
families, and health-care workers for clinical decision making
before and throughout the course of installing mechanical ven-
tilation. Therefore, the purpose of this studywas to estimate the
QOL utility, lifetime survival, quality-adjusted life expectancy
(QALE), and expected utility loss for patients using PMV.
Methods
The cohort and survival of PMV patients
We recruited all patients who were admitted to the intensive
care unit and later received care at a respiratory care center and
respiratory care ward in a teaching hospital in southern Taiwanbetween 1998 and 2007. The recruitment criterion for PMV pa-
tients was the need formechanical ventilation support formore
than 6 hours per day for 21 days [13]. Each patient was followed
from the 22nd day that he or she received PMVuntil they died or
were censored onDecember 31, 2007. TheKaplan-Meiermethod
was applied to estimate the survival function.
In general, when the patients are unable to have a normal
respiration function, mechanical ventilation is installed for
the support of life. It is commonly established in the intensive
or critical care unit, and usually a tracheotomy is performed to
provide a consistently patent airway. Even under the ventila-
tor support, such patients did not survive for more than 1 to 3
years, but occasionally there were patients with a longer sur-
vival. Thus, lifetime survival of PMV patients (up to 300
months) was obtained using a linear extrapolation of a logit-
transformed curve of the survival ratio between the PMV and
an age-, gender-matched reference population generated by
theMonte Carlomethod from the life table of the general pop-
ulation of Taiwan. The detailedmethod and themathematical
proof under the assumption of constant excess hazard can be
found in our previous reports [14–18] and are briefly summa-
rized below. Because the collection period of PMV patients
ranged from 1998 to 2007, we chose the life table of themiddle
year (2002) for the Monte Carlo simulation.
Survival function of the age-, gender-matched hypothetical
reference population
The life tables for the general population were obtained from
the vital statistics published by the Department of Statistics,
Ministry of the Interior, Executive Yuan, Taiwan [19]. Because
the individual survival time of the subjects in a hypothetical
cohort cannot be directly derived from the life table of the
general population, we used the Monte Carlo method to gen-
erate the simulated survival time of age- and gender-matched
hypothetical reference subjects for each patient in the PMV
cohorts. The total collection of hypothetical subjects was used
as the reference population. Then, the survival curve of the
reference population was obtained by applying the Kaplan-
Meier method to the simulated survival times.
Cross-sectional sample of PMV patients for utility
measurements of QOL
To estimate the QOL utility function for these patients, we re-
cruited a cross-sectional sample of PMV subjects [18] who, after
21 days, continued to receive care from five institutions in Tai-
wan. Informed consent was obtained from every patient and/or
his/her family caregiver, and the study commenced after the
approval of the Institutional Review Boards (IRBs) of Chia-Yi
ChristianHospital andNational TaiwanUniversityHospital. The
three local hospitals also approved the study after reviewing the
approval documents of the above twomajor IRBs.
The utility value of the QOL for PMV patients was measured
using the EuroQol five-dimensional (EQ-5D) questionnaire. It is a
preference-based, generic instrument [20,21] and has been ex-
tensively used in many critically ill patients based on multi-at-
tribute utility theory [22–24]. The five dimensions assessed by
the EQ-5D are mobility, self-care, usual activities, pain/discom-
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349V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 3 4 7 – 3 5 3fort, and anxiety/depression, each with three levels of severity
(no problems, some/moderate problems, and severe/extreme
problems). This provides a utility value that ranges from 0 to 1
based on the five-dimensional health state classification; 0 rep-
resents the worst health status and 1 represents perfect health.
For subjects with basic cognition who communicated their re-
sponses and achieved a score ofmore than 15 on amini-mental
state examination (MMSE) [25,26], we conducted QOL measure-
ments with the EQ-5D via direct face-to-face interview. Each
individual patient was cross-sectionally measured one time on
EQ-5D. When the patient’s consciousness was too poor to com-
municate with the interviewer, family caregivers and nurses
were used as proxies [27–30]. We have summarized the detailed
methods of validating measurements in another study [31].
Briefly, we invited both family caregivers and nurses who di-
rectly took care of the patient to also evaluate the five dimen-
sions of EQ-5D on the patient’s behalf based on his/her under-
standing. The results were directly compared with the patient’s
ownrating,which is considered thegoldstandard.Theduration-
to-date for eachmeasurement is defined fromthe22nddayafter
PMV to the date of the interview by the researcher. A cross-sec-
tional sample of patientswith PMVwasobtainedand thekernel-
type smoothingmethod (moving averageof thenearby 10%)was
performed to calculate themean QOL throughout the follow-up
time period of 9 years [17,18]. The QOL value after 9 years was
assumed to be the same as the end of follow-up time. We com-
Table 1 – Demographic and clinical characteristics of
patients under PMV in a cohort group to obtain the
survival function and a cross-sectional sample for
measurements of quality of life.
Characteristics Cohort
of PMV
Cross-sectional
sample of
patients under
PMV
Calendar years of collection 1998–2007 2008–2009
Total number of patients 633 142
Mean age in year (SD) 76 (12) 75 (12)
% Female 45 43
Major underlying diseases and
comorbidities
% Hypertension 48 28
% Diabetes mellitus 40 25
% Cerebrovascular diseases 31 18
% Chronic obstructive
pulmonary disease
27 32
% End-stage renal disease 13 11
% Asthma 7 4
% Liver cirrhosis 3 2
% Coronary artery disease 13 6
Reasons for mechanical
ventilation
% Apnea or required
resuscitation
12 7
% Ventilatory failure 46 45
% Oxygenation failure 14 6
% Post operation 10 7
% Airway protection 1 1
% Others 17 34PMV, prolonged mechanical ventilation; SD, standard deviation.paredour resultswith thevaluesystemsof theUnitedStatesand
the United Kingdom. [21,32].
Statistical analysis
Integration of survival and QOL functions, QALE, lifetime
utility loss, and health gap
The lifetime survival probabilities along the duration-to-dates
(or time after beginning PMV) weremultiplied (or adjusted) with
the QOL values measured from EQ-5D to obtain a quality-ad-
justed survival curve, of which the sum of the total area under
this curvewas theQALEwithQALYas thecommonunit [18]. The
expected lifetime utility loss for PMV patients was calculated by
assuming a uniform utility of one for the age- and gender-
matched reference subjects and subtracting the QALE of PMV
patients [14,16,18]. In other words, based on the hazard function
r vital statistics of Taiwan, we simulated survival functions of
en reference people of the same age and gender for every PMV
atient and assumed that the utility of their QOL is one that
ould have been the QALE of each PMV patient had they not
eveloped the condition. The health gap, usually considered an
ndicator of health inequality, was defined and calculated as the
roportion of expected loss of lifetime utility of patients with
MV in comparisonwith age- and gender-matchedhypothetical
eferents simulated from vital statistics of Taiwan [33]. To facil-
tate the computation, we used the MC-QAS software program
uilt on the R statistical package for quality adjusted survival
stimation and 300-month extrapolation, designed by Dr. Jing-
hiang Hwang, Institute of Statistical Science, Academia Sinica,
aipei, Taiwan which can be downloaded for free from the fol-
owing website: http://www.stat.sinica.edu.tw/jshwang.
Results
The medical records of 633 patients who fulfilled the defi-
Fig. 1 – The life expectancy (area under the dotted line) and
loss of life expectancy (shadowed area between the two
curves) in years for 633 patients under prolonged mechanical
ventilation (PMV) after extrapolation to 300 months.nition of PMV were abstracted and linked to the National
350 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 3 4 7 – 3 5 3Mortality Registry of Taiwan in 2007 to obtain their survival
status. Many suffered frommultiple co-morbidities, includ-
ing hypertension (about half), diabetes mellitus (about two-
fifths), stroke, and chronic obstructive pulmonary disease
(COPD), among others, as summarized in Table 1. More than
half required mechanical ventilation because of ventilation
failure resulting from the above multiple co-morbidities or
from cardiopulmonary resuscitation, whereas about one-
seventh needed such services because of chronic lung con-
ditions, including COPD. The overall 1-year survival rate
was 33%.
From 2008 to 2009 we also screened 177 patients from
five institutions and enrolled 142 patients with PMV (re-
sponse rate of 80%); 55 patients provided their EQ-5D ratings
directly and 87 were assessed only through either family
caregivers and/or nurses. The demographic and clinical
characteristics of the above two groups of PMV subjects are
summarized in Table 1.
The life expectancy was 1.95 years and is depicted as the
area under the survival curve of PMV patients in Figure 1.
The average loss of life expectancy of these patients was
8.48 years, whereas the difference between the survival
curve of age- and gender-matched referents and that of
PMV patients and is shown by the shadowed area in Figure
1. After adjustment for QOL utility values directly measured
on 55 patients who were able to respond, the QALE was 0.58
QALY, whereas QALE of patients with poor consciousness
were 0.28 and 0.29 QALY for EQ-5Dmeasured by family care-
givers and nurses, respectively. Assuming that the utility
value of each referent was one throughout their lifetime,
the loss of QALE for PMV patients was 9.87 QALY (upper
panel of Fig. 2), whereas the results for 87 patients with poor
cognition and inability to respond (MMSE15) were 10.17
and 10.16 QALY for utility values measured by family care-
givers and nurses, respectively. The sensitivity analysis of
substituting the utility values of the United States with
those from the United Kingdom did not show a significant
difference in QALE between patients and their proxies and
is summarized in Table 2. The health gap was 94% and 97%
for patients with a partial cognition and poor cognition, re-
spectively.
Discussion
This study estimates lifetime survival function and quality of
life in PMV patients while simultaneously obtaining the qual-
ity-adjusted life expectancy and the expected lifetime utility
loss, and providing empirical evidence to facilitate discussion
on health policy decision among patients, their families,
health-care workers, and the policy makers. We found that
the life expectancy of patients using PMV was 1.95 life years,
which is less than the 2.65 life years estimated byCox et al. [34]
through Markov model simulation. Moreover, the QALE esti-
mated by this studywas only 0.28 to 0.58 QALY,which ismuch
less than the 1.77 QALY reported previously [34]. Although
investigators would usually like to compare the results from
ex ante prediction with those of ex post outcome evaluation,
the two studies cannot be directly compared because ofmajordifferences in the recruited subjects and measurements. Our
study has amuch higher proportion of patientswith poor con-
sciousness (62% vs. 30%), the patients were on PMVmore than
21 days, and the patients were on average 10 years older than
theirs (mean ages 76 vs. 66 years) [34,35]. Thus, our subjects
had a poorer quality of life and lower 1-year survival rate (33%
vs. 42%) than others [23, 34–36]. Moreover, different types of
utilitymeasurements of QOLwere applied in different studies,
EQ-5D versus SF-36 or quality of well-being index. Hence, the
estimated QALE in our patients under PMV were lower than
those reported from previous studies. We therefore recom-
mend that future research on patients with normal or better
consciousness be conducted to determine the QALE more ac-
curately for suchpatientswith different age and gender strata.
Given the limited resources in health care, it is inevitable
that most countries with a national health insurance system
must consider the comparative cost-effectiveness of their de-
cisions on resource allocation, and the common unit of QALY
that simultaneously considers both mortality and morbidity
(or, survival and quality of life) has becomemore widely used.
TheNational Institute for Health andClinical Excellence in the
United Kingdom [37,38] is known worldwide for such prac-
tices. However, there are still controversial issues of distribu-
tive justice in bioethics concerning potential discrimination
Fig. 2 – Quality adjusted survival for patients undergoing
prolonged mechanical ventilation (PMV) after adjustment
of survival function (N=633) with the utility values of
quality of life measured with the EQ-5D. The upper and
lower panels depict the results of patients’ preference
values (N=55) and that of family caregivers’ on their behalf
(N=87), respectively, with the quality-adjusted life
expectancy of 0.58 and 0.28 quality-adjusted life years by
summing the areas under the quality-adjusted survival
curves (shaded areas).against the aged and disabled [39,40]. Daniels proposes in the
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351V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 3 4 7 – 3 5 3principle of distributive justice that everyone is entitled to
obtain health care up to their “normal life span,” if possible
[39], and this is adopted in the calculation of a health gap
proposed in the summarization of the population health [33].
he health gap was 94% and 97% for patients with a partial
ognition and poor cognition, respectively, indicating that
hese patients are more disadvantaged and deserve more re-
ources based on the principle of justice. Therefore, we rec-
mmend that more efforts be implemented to improve the
ong-term survival and QOL for PMV patients with different
nderlying causes or co-morbidities to improve the efficacy of
uch a treatment if the cost is paid by the patients themselves
r their private health insurances. If, however, the expense of
MV is paid by national health insurance, the results of this
tudy can facilitate a more reasonable decision among all
takeholders according to the principles of equity and effi-
iency. For example, are we willing to spend more resources
n PMV or child health, vaccinations, and preventive care,
mong others? Without the above data, the task of making
ealth decisions is generally difficult.
In Asian countries (including Taiwan), where patients and
heir families arenot accustomed topreparing theirwills early in
ife or signing “do not resuscitate” documents before they are
ritically ill, the estimates of QALE for patients with PMV are
elevant and can be the opening to begin a dialogue between all
takeholders and the public. The results provide the first evi-
ence to sound the wake-up call for the public to contemplate
nd openly discuss the principles of health resources distribu-
ion for the national health insurance on PMV care.
Our study has the following limitations. First, the validity
f the QOL measurement for critically ill patients with an im-
airment of cognition or even unconsciousness must be ad-
ressed. To resolve this difficulty, we conducted a survey of
he patient’s proxies that included both family caregivers and
urses who directly took care of the patient, which was re-
orted in other studies [27–29,34]. The results are summarized
n a separate report directly comparing the EQ-5D values of 55
atients with those rated by their family caregivers and
Table 2 – QALE (in years) and expected lifetime loss of utili
EQ-5D and patient’s cognition for sensitivity analysis.
Categories
Country of value system for EQ-5D U
Patients with partial cognition and ability to respond
(MMSE15, n55)
QOL measured by patients (n55) 0.7
QOL measured by family caregivers (n44) 0.6
QOL measured by nurses (n53) 0.7
Referents (age- and gender-matched) 10.4
Patients with poor cognition and inability to respond
(MMSE15, n87)
QOL measured by family caregivers (n81) 0.4
QOL measured by nurses (n81) 0.4
Referents (age- and gender-matched) 10.4
MMSE, mini-mental state exam; PMV, prolonged mechanical vent
standard error.urses [31]. Because EQ-5D contains only two dimensions thatrequire subjective rating, namely, pain/discomfort and anxi-
ety/depression, we foundminor differences of the final EQ-5D
values between the patient-caregiver pairs and patient-nurse
pairs,0.030.14, and 0.030.22, respectively. The results en-
abled us to stratify these patients according to the severity of
their cognitive ability deficits and to calculate the quality-ad-
justed life expectancy as a sensitivity analysis, which showed
that the difference between patients with good and poor con-
sciousness is less than 0.30 QALY (Table 2). Although our sam-
ple size was too small for us to further stratify into more cat-
egories according to age and gender, it seemed that the
differencemight not be large for patientswith poor conscious-
ness. Second, we assumed a uniform utility of one for the age-
and gender-matched reference subjects that over-estimated
the lifetime utility of the general population and also the ex-
pected lifetime utility loss of PMV patients. However, because
such an assumption is uniformly applied, the bias was mini-
mizedwhenwe calculated the health gaps for different health
conditions. Third, during the lifetime extrapolation of QOL
function it was assumed that the patients remained at the
same level of QOL near the end of follow-up. Such an assump-
tion could have resulted in an overestimation because the ac-
tual QOL might gradually decline as the patient ages. Fourth,
the accuracy of the estimation of QALE would have improved
if we had obtained quality-of-life measurements during the
follow-up of every patient in the PMV cohort. Unfortunately,
we were unable to conduct this study prospectively. Thus, we
simply took another consecutive, cross-sectional sample of
142 PMVpatientswith different duration-to-dates and applied
a smoothing method for the estimation of lifelong QOL func-
tion. We have demonstrated through simulation that a ran-
dom sample of more than 50 subjects would be adequate for
the above estimation, or, the relative bias would be less than
5% [18]. In fact, the PMV cohort to estimate survival function
and the cross-sectional sample of subjects under PMV for QOL
measurements seemed comparable in age, gender, and Glas-
gow Coma Scale (Table 1). Fifth, we used the age- and gender-
matched general population as the reference group to esti-
r patients under PMV based on different value systems of
QALE (SE) Expected lifetime loss of
utility (SE)
US UK US
) 0.58 (0.09) 9.73 (0.13) 9.87 (0.09)
) 0.61 (0.18) 9.80 (0.16) 9.84 (0.19)
) 0.64 (0.15) 9.77 (0.11) 9.81 (0.15)
) 10.45 (0.02) — —
) 0.28 (0.05) 9.98 (0.13) 10.17 (0.06)
) 0.29 (0.05) 9.99 (0.09) 10.16 (0.05)
) 10.45 (0.02) —
; QALE, quality-adjusted life expectancy; QOL, quality of life; SE,ty fo
K
4 (0.13
7 (0.15
0 (0.16
7 (0.02
4 (0.09
3 (0.09
2 (0.02
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than 1 daywithout ventilation support, it is almost impossible
or extremely difficult to collect another group of patients un-
der the same condition but without mechanical ventilation.
However, future studies are planned that will collect more
PMV cases and stratify them by different co-morbidities
and/or underlined diseases to determine if their survival and
QOL are different to further improve the cost-effectiveness for
such care. Finally, because each country may have different
quality of care, and hence, different survival and QOL func-
tions, the generalization of the results from this study to other
nations may be limited.
Conclusions
The life expectancy of an average 76-year-old patient under
PMV was about 1.95 years in Taiwan, which amounts to 0.58
QALY (partial consciousness) and 0.28 QALY (poor conscious-
ness) after an adjustment for quality of life measured by EQ-
5D. The estimate is useful to facilitate discussions among pa-
tients, their families, and health-care workers for clinical
decisionmaking early and throughout the course of installing
mechanical ventilation. Moreover, the results can also serve
as a starting point for a public dialogue on resource allocation
of the NHI on critical care, aging, and palliative care. Future
studies should further integrate medical cost into the estima-
tion of the cost per QALY gained together with consideration
of reduction of the health gap to preserve health equality.
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